Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Limulus Bio AB
AB
Dissolved
Org 5592337314
Research and experimental development on biotechnology
·
NACE 7211
Est. 2019 · 6 years old
4 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on biotechnology
/
Limulus Bio AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
16M
12M
8M
4M
0M
2020: 1M
1M
2020
2021: 6M (+500% vs 2020)
6M
+500%
2021
2022: 13M (+117% vs 2021)
13M
+117%
2022
EBITDA
SEK millions
1M
1M
1M
0M
0M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 1M
1M
2022
Income statement
SEK thousands
Item
2022
2021
2020
Revenue
12 612
5 713
1 026
Staff expenses
—
—
—
EBITDA
1 270
331
−444
Depreciation & amort.
−7
−7
−3
EBIT
1 263
324
−447
Net financials
—
−12
—
Profit before tax
1 263
312
−447
Tax
−261
−0
−0
Net profit
1 002
312
−447
Balance sheet
SEK thousands
Item
2022
2021
2020
Total assets
4 903
2 369
1 290
Equity
1 117
515
203
Long-term debt
0
0
0
Short-term debt
3 786
1 854
1 086
Total debt
3 786
1 854
1 086
Financial ratios
5-year trend
EBITDA margin
10.1%
This company
15.8%
Market median
This company
Market median
36% below market
2020
2022
Equity ratio
22.8%
This company
38.2%
Market median
This company
Market median
40% below market
2020
2022
Return on equity
89.7%
This company
18.4%
Market median
This company
Market median
388% above market
2020
2022
Net profit margin
7.9%
This company
8.1%
Market median
This company
Market median
2% below market
2020
2022
Asset turnover
2.57×
This company
1.12×
Market median
This company
Market median
129% above market
2020
2022
Debt / equity
3.39×
This company
0.62×
Market median
This company
Market median
447% above market
2020
2022
Annual reports & filings
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2019-12-01 – 2020-12-31
View
PDF
More on Limulus Bio AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
